NasdaqCM - Delayed Quote • USD
Pulse Biosciences, Inc. (PLSE)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 5:01 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -0.49 | -0.25 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | 200k | 9k | 700k | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 6/30/2023 |
---|---|---|---|---|
EPS Est. | -0.45 | -0.24 | -0.22 | -0.22 |
EPS Actual | -0.49 | -0.25 | -0.26 | -0.22 |
Difference | -0.04 | -0.01 | -0.04 | 0 |
Surprise % | -8.90% | -4.20% | -18.20% | 0.00% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
30 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
60 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
90 Days Ago | -0.22 | -0.22 | -0.89 | -0.9 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | PLSE | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 0.40% |
Next Qtr. | -- | -- | -- | 9.90% |
Current Year | -- | -- | -- | 4.30% |
Next Year | -- | -- | -- | 13.40% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | Maxim Group: Buy to Hold | 9/21/2022 |
Downgrade | HC Wainwright & Co.: Buy to Neutral | 5/13/2022 |
Maintains | Stephens & Co.: Overweight | 4/1/2022 |
Maintains | HC Wainwright & Co.: Buy | 4/1/2022 |
Maintains | HC Wainwright & Co.: Buy | 2/10/2022 |
Maintains | HC Wainwright & Co.: Buy | 11/16/2021 |
Related Tickers
KRMD KORU Medical Systems, Inc.
2.1400
+0.47%
NEPH Nephros, Inc.
2.1400
+3.88%
MLSS Milestone Scientific Inc.
0.5571
+3.17%
LMAT LeMaitre Vascular, Inc.
64.23
+2.33%
MMSI Merit Medical Systems, Inc.
74.18
+1.27%
NYXH Nyxoah S.A.
10.48
-4.03%
ICUI ICU Medical, Inc.
97.76
+1.43%
AKYA Akoya Biosciences, Inc.
3.8100
-2.31%
ATRC AtriCure, Inc.
23.17
+2.03%
OSUR OraSure Technologies, Inc.
5.53
+3.36%